- Re-designation of the four Executive Directors in line with expanded roles
- Board approves induction of Vinayak Chatterjee as Independent Director
Announcing the details of this change, Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, “As the healthcare landscape in the country and the region changes and expands, this strategic realignment, we believe, will enable Apollo to focus on growth opportunities in hospitals, pharmacies, clinics and health insurance while furthering its clinical leadership and service excellence. We aim to deepen our focus in each of these verticals as well as drive synergies between them using technology and an ecosystem focused on wellness, innovation and productivity.”
Apollo Hospitals has had a strong record of leadership centered on robust business performance and commitment to its customers and shareholders. It has demonstrated consistent growth in top line and profitability driven by its focus on clinical excellence and patient care. Our greatest asset is the trust that 40 million patients from 120 countries have reposed in our clinical acumen since our inception. This in turn, increases our responsibility to deliver even greater care to our patients and customers as well as our committed family of over 70,000 members along with a team of over 8000 highly skilled doctors who work relentlessly in our pursuit of excellence.
The reorganization has been designed to maximize the growth as envisaged in the strategy developed in close coordination with all our stakeholders including external consultants.
Similarly, the re-designation of the four Executive Directors is in keeping with the expanded roles and additional responsibilities being assigned to them aligned with the strategy, with a view to achieving the organization’s accelerated growth agenda.
Ms. Preetha Reddy will assume an expanded role and be re-designated as Executive Vice-Chairperson, Apollo Hospitals Enterprise Limited. Focused on Apollo’s core strength, she will work closely with the organization’s 8000 clinicians in reviewing global medical advancements and in introducing contemporary protocols to further enhance clinical outcomes. She will lead the organization’s thrust on continuous quality improvement processes to achieve the highest standards of patient satisfaction. Preetha will persevere to further build and strengthen engagement with doctors across the organization’s network. Considering the immense potential in international business, Preetha will directly lead this portfolio and drive Apollo’s aspiration of becoming the global healthcare destination. She will steer the Enterprise Risk Management portfolio for the company. In addition to her organizational responsibilities, Preetha will work closely with industry bodies and the State and Central Governments to advance policy matters on important healthcare issues.
Ms. Suneeta Reddy has displayed deep domain knowledge and foresight in guiding Apollo’s emergence as a formidable and financially sound hospital enterprise. She will now assume the role of Managing Director, Apollo Hospitals Enterprise Limited. She will lead the corporate strategy, corporate finance, funding and investments and will leverage M&As to achieve the accelerated pace of growth and optimize profitability. Ms. Suneeta will directly steer the hospital vertical and will also handle Brand and Marketing.
Ms. Shobana Kamineni will assume additional responsibilities and be re-designated as Executive Vice-Chairperson, Apollo Hospitals Enterprise Limited. She will continue to spearhead Apollo Pharmacy related initiatives, which is presently the fastest growing business within AHEL. In a short span of time, Apollo Pharmacy has grown to become not just the largest pharmacy chain in the country but also acquired a unique position among the top 5 retail companies in India due to the sheer size of its retail operations and geographic presence. Shobana will oversee the planning, design and execution of new projects and lead the Apollo Global Projects Consultancy Division. Shobana continues to be a Whole Time Director on the Board of Apollo Munich Health Insurance, the company she founded. The business, we believe, has a very strong growth potential.
Ms. Sangita Reddy will take charge as Joint Managing Director, Apollo Hospitals Enterprise Limited and will assume greater responsibilities which will include creating an IT enabled patient centric operation across the Apollo footprint and creating an unmatched continuum of care for patients. Sangita has always been focused on the need to create healthcare of the future and has championed the organization’s endeavours in the domain of telemedicine, e-health and mobile health. She will continue to steer Apollo’s thrust on research, innovation and healthcare initiatives. In growing the group’s retail healthcare foray, Sangita will also spearhead Retail Health, including Health & Lifestyle under Apollo Health and Lifestyle Ltd., the company running Clinics, Cradles and other retail service formats. She will lead the Human Resources and IT functions across all divisions of the Group and will continue to be the Chairperson of Apollo Knowledge, the education vertical of the group.
Dr. Reddy added, “We see enormous growth opportunities on which Apollo can capitalize; this restructuring will further facilitate our objective of leveraging on the company’s leadership and current business assets and platforms to execute against these opportunities. Our primary focus at Apollo is to continue on our path of growth and profitability in existing businesses while expanding to newer geographies, develop new areas in the healthcare business and harness the potential of technology to accelerate growth and innovation thereby continuing to significantly build shareholders value. While there is no change in our capital allocation plans as already communicated earlier, we believe that this structure will enhance our ability to invest and grow each of our key business platforms as we move forward.”
There would be no change in the existing terms of remuneration payable to the working Directors.
The Board today also approved the appointment of Mr. Vinayak Chatterjee as an Additional Director with effect from 2nd July 2014 to hold office as an Independent Director of the Company.
Dr. Reddy said, “We are delighted to have Vinayak on our Board as he brings to the fore immense versatility of experience as a strategic advisor who has guided domestic and international corporates, the Government of India, various Ministries dealing with infrastructure, as well as multilateral and bilateral institutions in the areas of infrastructure planning and implementation. He has been one of the leading proponents of the Public-Private Partnership (PPP) model for developing India’s infrastructure and I firmly believe that PPPPs which includes People participation would be key to ramping up the healthcare infrastructure in our country at an accelerated pace.”
About Apollo Hospitals Enterprise Ltd. (AHEL)
It was in 1983, that Dr. Prathap Reddy made a pioneering endeavour by launching India’s first corporate hospital - Apollo Hospital in Chennai. Now, as Asia largest and most trusted healthcare group, its presence includes over 8,600 beds across 50 Hospitals, 1,632 Pharmacies, 92 Primary Care and Diagnostic Clinics, 100 Telemedicine units across 10 countries. Health Insurance services, Global Projects Consultancy, 15 colleges of Nursing and Hospital Management, a Research Foundation with a focus on global Clinical Trials, epidemiological studies, stem cell & genetic research and the first Proton Therapy Center across Asia, Africa and Australia.
In a rare honor, the Government of India issued a commemorative stamp in recognition of Apollo's contribution, the first for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010. For more than 30 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innovation, world-class clinical services and cutting-edge technology. Our hospitals are consistently ranked amongst the best hospitals globally for advanced medical services and research.
Disclaimer
Some of the statements in this document that are not historical facts are forward looking statements. These forward-looking statements include our financial and growth projections as well as statements concerning our plans, strategies, intentions and beliefs concerning our business and the markets in which we operate.
These statements are based on information currently available to us, and we assume no obligation to update these statements as circumstances change. There are risks and uncertainties that could cause actual events to differ materially from these forward-looking statements. These risks include, but are not limited to, the level of market demand for our services, the highly-competitive market for the types of services that we offer, market conditions that could cause our customers to reduce their spending for our services, our ability to create, acquire and build new businesses and to grow our existing businesses, our ability to attract and retain qualified personnel, currency fluctuations and market conditions in India and elsewhere around the world, and other risks not specifically mentioned herein but those that are common to industry.
Further, this document may make references to reports and publications available in the public domain. Apollo Hospitals Enterprise Ltd. makes no representation as to their accuracy or that the company subscribes to those views / findings.
Media Contact Details: Kunal Addvant, Apollo Hospitals, ,+91-9891396000
Comments
Post a Comment